Navigation Links
University Hospitals Case Medical Center to begin clinical trial on experimental anti-TB drug
Date:7/29/2011

University Hospitals (UH) Case Medical Center will begin a Phase 1 clinical trial on a new experimental anti-tuberculosis drug called TMC207. This drug represents the first new class of anti-TB drugs in the past 60 years and it has activity against both drug-susceptible and drug-resistant TB.

The study is the first trial under a seven-year, $16.8 million contract awarded from the National Institutes of Health through the Hinckley-based research organization research organization Clinical Research Management (CRM) to UH Case Medical Center, Case Western Reserve University and Johns Hopkins University for first- in-human studies of new drugs for emerging infectious diseases.

TMC207 will be tested in 32 healthy individuals for its safety and tolerability, and to determine if its pharmacological activity is affected by repeat doses of other anti-TB drugs, rifabutin and rifampin, which are already in use and are often used in combination for treating TB.

The study will be led by Dr. Robert Salata, chief of the Division of Infectious Diseases at UH Case Medical Center and professor of medicine at Case Western Reserve University School of Medicine.

TB remains a major scourge. One third of the world's population is thought to be infected with it.


'/>"/>

Contact: George Stamatis
george.stamatis@uhhospitals.org
216-844-3667
University Hospitals Case Medical Center
Source:Eurekalert

Page: 1

Related medicine news :

1. University of Houston student awarded Hogg Foundation Scholarship
2. University of Leicester develops test for classifying force used in bottle stabbings
3. University of Maryland researchers discover possible drug targets for common non-Hodgkins lymphoma
4. Columbia University Medical Center receives $38.9 million to help translate science into treatment
5. Wayne State University engineering student receives American Tinnitus Association award
6. Mainz University Medical Center deploys new system for therapy of metastatic spinal tumors
7. Wayne State University researcher argues that sex reduces genetic variation
8. New book by Indiana University physicians slays health myths we all thought were true
9. Health providers should emphasize breast cancer screening, Wayne State University research finds
10. Researchers at Oregon Health & Science University discover MS-like disease in monkeys
11. Religion benefits traumatic brain injury victims, Wayne State University research finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... , ... May 02, 2016 , ... East Los Angeles ... extractions. Currently, patients can visit Dr. Assili to receive any dental extraction treatment for ... and it expires June 30, 2016. With the lower price, patients can more easily ...
(Date:5/2/2016)... ... 2016 , ... Further establishing itself as a leader in natural pet products ... Boxes were selected from over 1,000 entrants as a winner and recipient of the ... chews for dogs are a favorite product among pet-parents worldwide, as each whimsical knobby ...
(Date:5/2/2016)... ... 2016 , ... Visceral fat, also known as “deep fat” ... and pancreas. If not properly addressed, visceral fat can lead to serious health ... Oncology and Palliative Care, warns against the dangers of visceral fat. “Just because ...
(Date:5/2/2016)... ... ... According to an American Psychological Association article, the Centers for ... age of 18. Of those who survive, many still face effects as they reach ... her new book, Lyah! Lyah! Pants on Fyah!, she shares stories from women who ...
(Date:5/2/2016)... ... May 02, 2016 , ... TeleMedCo™, a ... designed to automate and improve the rapid diagnosis, triage and admission of patients ... platform, application, and mobile experience for the first time at GENBAND’s Perspectives16 conference. ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... TapImmune,Inc. (TPIV), a clinical-stage immune-oncology company ... and vaccines for the treatment of cancer & metastatic disease, ... Growth Capital Expo to be held on May 3 ... in Las Vegas, Nevada.  The Company presentation will be ... by Dr. John N. Bonfiglio a TapImmune Board ...
(Date:4/27/2016)... MARLBOROUGH, Mass., April 27, 2016  Hologic, Inc. ... Company,s financial results for the fiscal second quarter ... share (EPS) of $0.24 increased 41.2%, and non-GAAP ... $693.3 million increased 5.8% on a reported basis, ... "We posted another good quarter, highlighted ...
(Date:4/27/2016)... , le 27 Avril 2016 ... d,affaires a progressé de +5% sur le trimestre, ... récurrentes de consommables  Croissance de +16% ... Mauna Kea Technologies (Euronext : MKEA, ... d,endomicroscopie confocale laser, annonce aujourd,hui son chiffre d,affaires ...
Breaking Medicine Technology: